3 ASX Penny Stocks With A$400M Market Cap

In This Article:

The Australian market has been relatively stable, with the ASX200 closing slightly down by 0.06% as investors await key economic data, particularly the upcoming Quarterly CPI figures. In this context, penny stocks—often representing smaller or newer companies—continue to capture attention for their potential value and growth opportunities at lower price points. Despite being a somewhat outdated term, these stocks can still offer significant upside when backed by strong financials and solid fundamentals.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

LaserBond (ASX:LBL)

A$0.62

A$74.43M

★★★★★★

Embark Early Education (ASX:EVO)

A$0.80

A$127.64M

★★★★☆☆

Helloworld Travel (ASX:HLO)

A$1.78

A$292.36M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.57

A$334.88M

★★★★★☆

MaxiPARTS (ASX:MXI)

A$1.895

A$99.57M

★★★★★★

Navigator Global Investments (ASX:NGI)

A$1.685

A$823.33M

★★★★★☆

Perenti (ASX:PRN)

A$1.19

A$1.1B

★★★★★★

Atlas Pearls (ASX:ATP)

A$0.13

A$59.91M

★★★★★★

GTN (ASX:GTN)

A$0.47

A$93.09M

★★★★★★

Joyce (ASX:JYC)

A$3.98

A$117.4M

★★★★★★

Click here to see the full list of 1,029 stocks from our ASX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Horizon Oil

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Horizon Oil Limited, along with its subsidiaries, is involved in the exploration, development, and production of oil and gas properties across China, New Zealand, and Australia with a market capitalization of A$308.81 million.

Operations: The company's revenue segments include $76.83 million from China Exploration and Development, $34.24 million from New Zealand Exploration and Development, and $0.39 million from Australia Development.

Market Cap: A$308.81M

Horizon Oil's market capitalization of A$308.81 million places it in the realm of smaller stocks, with its operations spanning China, New Zealand, and Australia. Despite a decline in earnings and net profit margins from the previous year, the company remains financially robust with more cash than debt and operating cash flow well covering its liabilities. Recent board changes introduce seasoned leadership with Dr. Peter Goode joining as an independent non-executive director. However, challenges persist as earnings growth has been negative recently despite a history of profit growth over five years at 14.9% annually.

ASX:HZN Revenue & Expenses Breakdown as at Oct 2024
ASX:HZN Revenue & Expenses Breakdown as at Oct 2024

Metals X

Simply Wall St Financial Health Rating: ★★★★★☆